ZA200201401B - Iren protein, its preparation and use. - Google Patents

Iren protein, its preparation and use. Download PDF

Info

Publication number: ZA200201401B
Authority: ZA; South Africa
Prior art keywords: protein; iren; traf2; sequence; cells
Prior art date: 1999-09-02

Application number

ZA200201401A

Other languages

English (en)

Inventor

David Wallach

Nikolay Malinin

Indranil Sinha

Stefan Leu

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-02

Filing date

2002-02-19

Publication date

2003-05-28

2002-02-19 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

2003-05-28 Publication of ZA200201401B publication Critical patent/ZA200201401B/en

Links

108090000623 proteins and genes Proteins 0.000 title claims description 379
102000004169 proteins and genes Human genes 0.000 title claims description 352
XAEWZDYWZHIUCT-UHFFFAOYSA-N desipramine hydrochloride Chemical compound [H+].[Cl-].C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 XAEWZDYWZHIUCT-UHFFFAOYSA-N 0.000 title claims description 281
238000002360 preparation method Methods 0.000 title description 9
210000004027 cell Anatomy 0.000 claims description 173
102100034779 TRAF family member-associated NF-kappa-B activator Human genes 0.000 claims description 170
108090000925 TNF receptor-associated factor 2 Proteins 0.000 claims description 169
239000012634 fragment Substances 0.000 claims description 147
102000001708 Protein Isoforms Human genes 0.000 claims description 115
108010029485 Protein Isoforms Proteins 0.000 claims description 115
238000000034 method Methods 0.000 claims description 113
230000000694 effects Effects 0.000 claims description 105
230000027455 binding Effects 0.000 claims description 95
102000005962 receptors Human genes 0.000 claims description 79
108020003175 receptors Proteins 0.000 claims description 79
108010057466 NF-kappa B Proteins 0.000 claims description 70
102000003945 NF-kappa B Human genes 0.000 claims description 69
239000013598 vector Substances 0.000 claims description 68
108090000765 processed proteins & peptides Proteins 0.000 claims description 62
230000001404 mediated effect Effects 0.000 claims description 61
108091028043 Nucleic acid sequence Proteins 0.000 claims description 60
239000003446 ligand Substances 0.000 claims description 56
102000004196 processed proteins & peptides Human genes 0.000 claims description 46
108020004414 DNA Proteins 0.000 claims description 44
230000003993 interaction Effects 0.000 claims description 41
239000002299 complementary DNA Substances 0.000 claims description 39
230000006698 induction Effects 0.000 claims description 36
229920001184 polypeptide Polymers 0.000 claims description 30
241000700605 Viruses Species 0.000 claims description 25
150000001413 amino acids Chemical class 0.000 claims description 25
230000014509 gene expression Effects 0.000 claims description 25
239000008194 pharmaceutical composition Substances 0.000 claims description 25
238000012216 screening Methods 0.000 claims description 24
125000003275 alpha amino acid group Chemical group 0.000 claims description 23
230000001413 cellular effect Effects 0.000 claims description 22
239000000203 mixture Substances 0.000 claims description 22
108091034117 Oligonucleotide Proteins 0.000 claims description 20
230000003834 intracellular effect Effects 0.000 claims description 20
241001465754 Metazoa Species 0.000 claims description 18
239000002773 nucleotide Substances 0.000 claims description 18
125000003729 nucleotide group Chemical group 0.000 claims description 18
108090000994 Catalytic RNA Proteins 0.000 claims description 17
102000053642 Catalytic RNA Human genes 0.000 claims description 17
108091092562 ribozyme Proteins 0.000 claims description 17
238000009396 hybridization Methods 0.000 claims description 15
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims description 14
230000004068 intracellular signaling Effects 0.000 claims description 14
102000003298 tumor necrosis factor receptor Human genes 0.000 claims description 14
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 13
108091008604 NGF receptors Proteins 0.000 claims description 12
108020004999 messenger RNA Proteins 0.000 claims description 12
230000001575 pathological effect Effects 0.000 claims description 12
102000053602 DNA Human genes 0.000 claims description 10
238000001042 affinity chromatography Methods 0.000 claims description 10
230000002265 prevention Effects 0.000 claims description 10
239000004480 active ingredient Substances 0.000 claims description 9
238000004519 manufacturing process Methods 0.000 claims description 9
239000000284 extract Substances 0.000 claims description 8
230000002068 genetic effect Effects 0.000 claims description 8
238000001086 yeast two-hybrid system Methods 0.000 claims description 8
125000000539 amino acid group Chemical group 0.000 claims description 7
230000005764 inhibitory process Effects 0.000 claims description 7
238000001890 transfection Methods 0.000 claims description 7
230000000692 anti-sense effect Effects 0.000 claims description 6
108091026890 Coding region Proteins 0.000 claims description 5
102000018697 Membrane Proteins Human genes 0.000 claims description 5
108010052285 Membrane Proteins Proteins 0.000 claims description 5
238000003780 insertion Methods 0.000 claims description 5
230000037431 insertion Effects 0.000 claims description 5
102000000844 Cell Surface Receptors Human genes 0.000 claims description 4
108010001857 Cell Surface Receptors Proteins 0.000 claims description 4
230000002452 interceptive effect Effects 0.000 claims description 4
238000010397 one-hybrid screening Methods 0.000 claims description 4
230000000903 blocking effect Effects 0.000 claims description 3
239000011159 matrix material Substances 0.000 claims description 3
239000012504 chromatography matrix Substances 0.000 claims description 2
238000000605 extraction Methods 0.000 claims description 2
230000004481 post-translational protein modification Effects 0.000 claims description 2
230000001131 transforming effect Effects 0.000 claims description 2
230000003612 virological effect Effects 0.000 claims description 2
235000018102 proteins Nutrition 0.000 description 270
230000004913 activation Effects 0.000 description 75
108050000808 TNF receptor-associated factor TRAF Proteins 0.000 description 66
102000008889 TNF receptor-associated factor TRAF Human genes 0.000 description 66
108060008682 Tumor Necrosis Factor Proteins 0.000 description 46
102000003390 tumor necrosis factor Human genes 0.000 description 35
102000000160 Tumor Necrosis Factor Receptor-Associated Peptides and Proteins Human genes 0.000 description 34
108010080432 Tumor Necrosis Factor Receptor-Associated Peptides and Proteins Proteins 0.000 description 34
102000014914 Carrier Proteins Human genes 0.000 description 30
108091008324 binding proteins Proteins 0.000 description 30
235000001014 amino acid Nutrition 0.000 description 27
102100022219 NF-kappa-B essential modulator Human genes 0.000 description 23
101710090077 NF-kappa-B essential modulator Proteins 0.000 description 23
108091000080 Phosphotransferase Proteins 0.000 description 22
239000000427 antigen Substances 0.000 description 22
102000020233 phosphotransferase Human genes 0.000 description 22
108091007433 antigens Proteins 0.000 description 20
102000036639 antigens Human genes 0.000 description 20
238000003556 assay Methods 0.000 description 18
238000012217 deletion Methods 0.000 description 17
230000037430 deletion Effects 0.000 description 17
239000003112 inhibitor Substances 0.000 description 17
230000006870 function Effects 0.000 description 16
230000011664 signaling Effects 0.000 description 15
239000007787 solid Substances 0.000 description 15
238000006467 substitution reaction Methods 0.000 description 15
102100021892 Inhibitor of nuclear factor kappa-B kinase subunit alpha Human genes 0.000 description 14
-1 MORT-1 Proteins 0.000 description 14
102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 14
238000001514 detection method Methods 0.000 description 14
230000019491 signal transduction Effects 0.000 description 14
101150028668 APO1 gene Proteins 0.000 description 13
238000006243 chemical reaction Methods 0.000 description 13
230000001939 inductive effect Effects 0.000 description 13
230000037361 pathway Effects 0.000 description 13
238000012360 testing method Methods 0.000 description 13
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
101710110357 Inhibitor of nuclear factor kappa-B kinase subunit alpha Proteins 0.000 description 12
239000000523 sample Substances 0.000 description 12
210000001519 tissue Anatomy 0.000 description 12
230000004071 biological effect Effects 0.000 description 11
210000004899 c-terminal region Anatomy 0.000 description 11
238000003752 polymerase chain reaction Methods 0.000 description 11
230000008569 process Effects 0.000 description 11
238000010396 two-hybrid screening Methods 0.000 description 11
101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 10
102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 10
230000004044 response Effects 0.000 description 10
102000004190 Enzymes Human genes 0.000 description 9
108090000790 Enzymes Proteins 0.000 description 9
102100039556 Galectin-4 Human genes 0.000 description 9
210000000170 cell membrane Anatomy 0.000 description 9
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
229940088598 enzyme Drugs 0.000 description 9
238000011065 in-situ storage Methods 0.000 description 9
230000002401 inhibitory effect Effects 0.000 description 9
230000026731 phosphorylation Effects 0.000 description 9
238000006366 phosphorylation reaction Methods 0.000 description 9
238000010561 standard procedure Methods 0.000 description 9
101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 8
102100022501 Receptor-interacting serine/threonine-protein kinase 1 Human genes 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
150000001875 compounds Chemical class 0.000 description 8
229940079593 drug Drugs 0.000 description 8
239000003814 drug Substances 0.000 description 8
238000002741 site-directed mutagenesis Methods 0.000 description 8
239000007790 solid phase Substances 0.000 description 8
239000000243 solution Substances 0.000 description 8
239000000758 substrate Substances 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
101000850748 Homo sapiens Tumor necrosis factor receptor type 1-associated DEATH domain protein Proteins 0.000 description 7
241001529936 Murinae Species 0.000 description 7
108700026244 Open Reading Frames Proteins 0.000 description 7
108090000829 Ribosome Inactivating Proteins Proteins 0.000 description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
102100033081 Tumor necrosis factor receptor type 1-associated DEATH domain protein Human genes 0.000 description 7
230000003321 amplification Effects 0.000 description 7
210000003719 b-lymphocyte Anatomy 0.000 description 7
239000003795 chemical substances by application Substances 0.000 description 7
238000010367 cloning Methods 0.000 description 7
238000003199 nucleic acid amplification method Methods 0.000 description 7
102100023995 Beta-nerve growth factor Human genes 0.000 description 6
101150013553 CD40 gene Proteins 0.000 description 6
108090000538 Caspase-8 Proteins 0.000 description 6
102000004091 Caspase-8 Human genes 0.000 description 6
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
108050006617 Interleukin-1 receptor Proteins 0.000 description 6
102000019223 Interleukin-1 receptor Human genes 0.000 description 6
108010025020 Nerve Growth Factor Proteins 0.000 description 6
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
229960002685 biotin Drugs 0.000 description 6
235000020958 biotin Nutrition 0.000 description 6
239000011616 biotin Substances 0.000 description 6
230000008859 change Effects 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
238000011534 incubation Methods 0.000 description 6
239000012528 membrane Substances 0.000 description 6
230000004048 modification Effects 0.000 description 6
238000012986 modification Methods 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
230000032258 transport Effects 0.000 description 6
102100028501 Galanin peptides Human genes 0.000 description 5
239000004365 Protease Substances 0.000 description 5
102000001253 Protein Kinase Human genes 0.000 description 5
210000001744 T-lymphocyte Anatomy 0.000 description 5
102100027651 TRAF-interacting protein with FHA domain-containing protein A Human genes 0.000 description 5
101710144564 TRAF-interacting protein with FHA domain-containing protein A Proteins 0.000 description 5
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
102000035181 adaptor proteins Human genes 0.000 description 5
108091005764 adaptor proteins Proteins 0.000 description 5
238000007792 addition Methods 0.000 description 5
230000006907 apoptotic process Effects 0.000 description 5
239000012472 biological sample Substances 0.000 description 5
101150055276 ced-3 gene Proteins 0.000 description 5
230000030833 cell death Effects 0.000 description 5
238000012761 co-transfection Methods 0.000 description 5
230000000295 complement effect Effects 0.000 description 5
210000000805 cytoplasm Anatomy 0.000 description 5
230000003013 cytotoxicity Effects 0.000 description 5
231100000135 cytotoxicity Toxicity 0.000 description 5
230000034994 death Effects 0.000 description 5
230000002950 deficient Effects 0.000 description 5
230000002939 deleterious effect Effects 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
201000010099 disease Diseases 0.000 description 5
230000002255 enzymatic effect Effects 0.000 description 5
230000031146 intracellular signal transduction Effects 0.000 description 5
239000000463 material Substances 0.000 description 5
230000007246 mechanism Effects 0.000 description 5
230000035772 mutation Effects 0.000 description 5
239000013612 plasmid Substances 0.000 description 5
108060006633 protein kinase Proteins 0.000 description 5
238000000746 purification Methods 0.000 description 5
238000012552 review Methods 0.000 description 5
239000000126 substance Substances 0.000 description 5
238000011144 upstream manufacturing Methods 0.000 description 5
208000030507 AIDS Diseases 0.000 description 4
102100022790 BTB/POZ domain-containing protein KCTD11 Human genes 0.000 description 4
230000004568 DNA-binding Effects 0.000 description 4
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
108060001084 Luciferase Proteins 0.000 description 4
239000005089 Luciferase Substances 0.000 description 4
241000699670 Mus sp. Species 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
108091005804 Peptidases Proteins 0.000 description 4
102000035195 Peptidases Human genes 0.000 description 4
102000004399 TNF receptor-associated factor 3 Human genes 0.000 description 4
108090000922 TNF receptor-associated factor 3 Proteins 0.000 description 4
102000003714 TNF receptor-associated factor 6 Human genes 0.000 description 4
108090000009 TNF receptor-associated factor 6 Proteins 0.000 description 4
102000040945 Transcription factor Human genes 0.000 description 4
108091023040 Transcription factor Proteins 0.000 description 4
102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 4
238000013459 approach Methods 0.000 description 4
239000000872 buffer Substances 0.000 description 4
230000006721 cell death pathway Effects 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
230000001086 cytosolic effect Effects 0.000 description 4
238000013461 design Methods 0.000 description 4
239000013604 expression vector Substances 0.000 description 4
239000007850 fluorescent dye Substances 0.000 description 4
230000004927 fusion Effects 0.000 description 4
YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 4
238000010166 immunofluorescence Methods 0.000 description 4
238000001727 in vivo Methods 0.000 description 4
230000006662 intracellular pathway Effects 0.000 description 4
230000002018 overexpression Effects 0.000 description 4
230000035699 permeability Effects 0.000 description 4
230000003389 potentiating effect Effects 0.000 description 4
108020003519 protein disulfide isomerase Proteins 0.000 description 4
230000007017 scission Effects 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
230000004083 survival effect Effects 0.000 description 4
230000004654 survival pathway Effects 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
108020004705 Codon Proteins 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
101150094690 GAL1 gene Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
101150009006 HIS3 gene Proteins 0.000 description 3
101000590272 Homo sapiens 26S proteasome non-ATPase regulatory subunit 2 Proteins 0.000 description 3
101100121078 Homo sapiens GAL gene Proteins 0.000 description 3
101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 3
241000725303 Human immunodeficiency virus Species 0.000 description 3
206010061218 Inflammation Diseases 0.000 description 3
102000000589 Interleukin-1 Human genes 0.000 description 3
108010002352 Interleukin-1 Proteins 0.000 description 3
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
108010091221 Lymphotoxin beta Receptor Proteins 0.000 description 3
102000043136 MAP kinase family Human genes 0.000 description 3
108091054455 MAP kinase family Proteins 0.000 description 3
108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 description 3
102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 description 3
108700008625 Reporter Genes Proteins 0.000 description 3
101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
102000004398 TNF receptor-associated factor 1 Human genes 0.000 description 3
108090000920 TNF receptor-associated factor 1 Proteins 0.000 description 3
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
102100022156 Tumor necrosis factor receptor superfamily member 3 Human genes 0.000 description 3
102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
231100000354 acute hepatitis Toxicity 0.000 description 3
125000002252 acyl group Chemical group 0.000 description 3
125000001931 aliphatic group Chemical group 0.000 description 3
239000005557 antagonist Substances 0.000 description 3
230000033228 biological regulation Effects 0.000 description 3
239000001506 calcium phosphate Substances 0.000 description 3
229960001714 calcium phosphate Drugs 0.000 description 3
229910000389 calcium phosphate Inorganic materials 0.000 description 3
235000011010 calcium phosphates Nutrition 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
239000000969 carrier Substances 0.000 description 3
230000022534 cell killing Effects 0.000 description 3
210000000349 chromosome Anatomy 0.000 description 3
230000004186 co-expression Effects 0.000 description 3
230000006378 damage Effects 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
230000002708 enhancing effect Effects 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
239000012530 fluid Substances 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
208000006454 hepatitis Diseases 0.000 description 3
102000058099 human PSMD2 Human genes 0.000 description 3
210000004408 hybridoma Anatomy 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
238000013198 immunometric assay Methods 0.000 description 3
238000001114 immunoprecipitation Methods 0.000 description 3
230000004054 inflammatory process Effects 0.000 description 3
230000002147 killing effect Effects 0.000 description 3
238000000021 kinase assay Methods 0.000 description 3
238000002372 labelling Methods 0.000 description 3
101150066555 lacZ gene Proteins 0.000 description 3
208000032839 leukemia Diseases 0.000 description 3
238000003670 luciferase enzyme activity assay Methods 0.000 description 3
210000004698 lymphocyte Anatomy 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
239000002184 metal Substances 0.000 description 3
150000007523 nucleic acids Chemical class 0.000 description 3
210000004940 nucleus Anatomy 0.000 description 3
150000002894 organic compounds Chemical class 0.000 description 3
238000003127 radioimmunoassay Methods 0.000 description 3
230000007115 recruitment Effects 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
230000007781 signaling event Effects 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
108091006106 transcriptional activators Proteins 0.000 description 3
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
238000005406 washing Methods 0.000 description 3
102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
208000023275 Autoimmune disease Diseases 0.000 description 2
238000011725 BALB/c mouse Methods 0.000 description 2
101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 2
230000006820 DNA synthesis Effects 0.000 description 2
102000010170 Death domains Human genes 0.000 description 2
108050001718 Death domains Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
108700024394 Exon Proteins 0.000 description 2
102100026693 FAS-associated death domain protein Human genes 0.000 description 2
108010008488 Glycylglycine Proteins 0.000 description 2
101001043764 Homo sapiens Inhibitor of nuclear factor kappa-B kinase subunit alpha Proteins 0.000 description 2
101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 description 2
101001059982 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 5 Proteins 0.000 description 2
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 2
101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 2
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 2
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 2
102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 description 2
101710138729 Interleukin-18 receptor accessory protein Proteins 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 description 2
102100028195 Mitogen-activated protein kinase kinase kinase kinase 5 Human genes 0.000 description 2
OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 2
102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 description 2
108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 description 2
229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
108010076504 Protein Sorting Signals Proteins 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
206010040070 Septic Shock Diseases 0.000 description 2
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
102100023132 Transcription factor Jun Human genes 0.000 description 2
102000008864 Translin Human genes 0.000 description 2
102100040247 Tumor necrosis factor Human genes 0.000 description 2
102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 2
108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
230000009471 action Effects 0.000 description 2
125000004423 acyloxy group Chemical group 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
238000000211 autoradiogram Methods 0.000 description 2
239000011324 bead Substances 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
239000013060 biological fluid Substances 0.000 description 2
108010053098 biotin receptor Proteins 0.000 description 2
201000011510 cancer Diseases 0.000 description 2
150000001768 cations Chemical class 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
108091006116 chimeric peptides Proteins 0.000 description 2
BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 2
230000021615 conjugation Effects 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
230000000445 cytocidal effect Effects 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
239000000539 dimer Substances 0.000 description 2
238000009826 distribution Methods 0.000 description 2
POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
239000012636 effector Substances 0.000 description 2
239000002158 endotoxin Substances 0.000 description 2
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
229940014144 folate Drugs 0.000 description 2
108020005243 folate receptor Proteins 0.000 description 2
102000006815 folate receptor Human genes 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
235000019152 folic acid Nutrition 0.000 description 2
239000011724 folic acid Substances 0.000 description 2
229940043257 glycylglycine Drugs 0.000 description 2
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
230000007124 immune defense Effects 0.000 description 2
230000003053 immunization Effects 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
239000012133 immunoprecipitate Substances 0.000 description 2
238000012744 immunostaining Methods 0.000 description 2
230000003308 immunostimulating effect Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000010354 integration Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
125000005647 linker group Chemical group 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
210000005229 liver cell Anatomy 0.000 description 2
238000004020 luminiscence type Methods 0.000 description 2
239000006166 lysate Substances 0.000 description 2
239000012139 lysis buffer Substances 0.000 description 2
150000002739 metals Chemical class 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
238000000386 microscopy Methods 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
238000006384 oligomerization reaction Methods 0.000 description 2
238000010647 peptide synthesis reaction Methods 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
230000008092 positive effect Effects 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
230000004952 protein activity Effects 0.000 description 2
102000021127 protein binding proteins Human genes 0.000 description 2
108091011138 protein binding proteins Proteins 0.000 description 2
230000004850 protein–protein interaction Effects 0.000 description 2
238000000163 radioactive labelling Methods 0.000 description 2
230000036303 septic shock Effects 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
238000010186 staining Methods 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
210000001550 testis Anatomy 0.000 description 2
230000032895 transmembrane transport Effects 0.000 description 2
210000004881 tumor cell Anatomy 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
239000011534 wash buffer Substances 0.000 description 2
238000001262 western blot Methods 0.000 description 2
229910052725 zinc Inorganic materials 0.000 description 2
239000011701 zinc Substances 0.000 description 2
ALZSTTDFHZHSCA-RNVDEAKXSA-N (4s)-4-[[(2s)-2-acetamido-3-carboxypropanoyl]amino]-5-[[(2s)-1-[[(2s)-3-carboxy-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC1=CC(=O)OC2=CC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(C)=O)C(C)C)=CC=C21 ALZSTTDFHZHSCA-RNVDEAKXSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
DVGKRPYUFRZAQW-UHFFFAOYSA-N 3 prime Natural products CC(=O)NC1OC(CC(O)C1C(O)C(O)CO)(OC2C(O)C(CO)OC(OC3C(O)C(O)C(O)OC3CO)C2O)C(=O)O DVGKRPYUFRZAQW-UHFFFAOYSA-N 0.000 description 1
108020005345 3' Untranslated Regions Proteins 0.000 description 1
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 1
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
102100031315 AP-2 complex subunit mu Human genes 0.000 description 1
108010022579 ATP dependent 26S protease Proteins 0.000 description 1
108010021160 Ac-aspartyl-glutamyl-valyl-aspartyl-aminomethylcoumarin Proteins 0.000 description 1
108010022752 Acetylcholinesterase Proteins 0.000 description 1
102000012440 Acetylcholinesterase Human genes 0.000 description 1
108010000239 Aequorin Proteins 0.000 description 1
CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
102000008102 Ankyrins Human genes 0.000 description 1
108010049777 Ankyrins Proteins 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
101100221077 Arabidopsis thaliana CML12 gene Proteins 0.000 description 1
JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 1
108010002913 Asialoglycoproteins Proteins 0.000 description 1
QCWJKJLNCFEVPQ-WHFBIAKZSA-N Asn-Gln Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O QCWJKJLNCFEVPQ-WHFBIAKZSA-N 0.000 description 1
CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 description 1
108010024976 Asparaginase Proteins 0.000 description 1
102000015790 Asparaginase Human genes 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
108090000426 Caspase-1 Proteins 0.000 description 1
102100029855 Caspase-3 Human genes 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
101710104316 Cell surface-binding protein Proteins 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
102000003910 Cyclin D Human genes 0.000 description 1
108090000259 Cyclin D Proteins 0.000 description 1
YXQDRIRSAHTJKM-IMJSIDKUSA-N Cys-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YXQDRIRSAHTJKM-IMJSIDKUSA-N 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
NBSCHQHZLSJFNQ-QTVWNMPRSA-N D-Mannose-6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O NBSCHQHZLSJFNQ-QTVWNMPRSA-N 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
102100021616 Ephrin type-A receptor 4 Human genes 0.000 description 1
241001524679 Escherichia virus M13 Species 0.000 description 1
XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
108010020195 FLAG peptide Proteins 0.000 description 1
108010077716 Fas-Associated Death Domain Protein Proteins 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
108010001515 Galectin 4 Proteins 0.000 description 1
DXJZITDUDUPINW-WHFBIAKZSA-N Gln-Asn Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O DXJZITDUDUPINW-WHFBIAKZSA-N 0.000 description 1
FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 description 1
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
102100022624 Glucoamylase Human genes 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 1
108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 1
VPZXBVLAVMBEQI-VKHMYHEASA-N Glycyl-alanine Chemical compound OC(=O)[C@H](C)NC(=O)CN VPZXBVLAVMBEQI-VKHMYHEASA-N 0.000 description 1
HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
108700010909 HTLV-1 proteins Proteins 0.000 description 1
101710154606 Hemagglutinin Proteins 0.000 description 1
108091027305 Heteroduplex Proteins 0.000 description 1
WSDOHRLQDGAOGU-BQBZGAKWSA-N His-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 WSDOHRLQDGAOGU-BQBZGAKWSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000796047 Homo sapiens AP-2 complex subunit mu Proteins 0.000 description 1
101000793880 Homo sapiens Caspase-3 Proteins 0.000 description 1
101100065486 Homo sapiens EPHA4 gene Proteins 0.000 description 1
101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 description 1
101100508538 Homo sapiens IKBKE gene Proteins 0.000 description 1
101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 1
101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
101000835082 Homo sapiens TCF3 fusion partner Proteins 0.000 description 1
101000847066 Homo sapiens Translin-associated protein X Proteins 0.000 description 1
101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
108700002232 Immediate-Early Genes Proteins 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
102100021854 Inhibitor of nuclear factor kappa-B kinase subunit beta Human genes 0.000 description 1
101710205525 Inhibitor of nuclear factor kappa-B kinase subunit beta Proteins 0.000 description 1
102100021857 Inhibitor of nuclear factor kappa-B kinase subunit epsilon Human genes 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102100039065 Interleukin-1 beta Human genes 0.000 description 1
102000004557 Interleukin-18 Receptors Human genes 0.000 description 1
108010017537 Interleukin-18 Receptors Proteins 0.000 description 1
102100039340 Interleukin-18 receptor 1 Human genes 0.000 description 1
101710184759 Interleukin-18 receptor 1 Proteins 0.000 description 1
102000001702 Intracellular Signaling Peptides and Proteins Human genes 0.000 description 1
108010068964 Intracellular Signaling Peptides and Proteins Proteins 0.000 description 1
102000004310 Ion Channels Human genes 0.000 description 1
108090000862 Ion Channels Proteins 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
XNSAINXGIQZQOO-UHFFFAOYSA-N L-pyroglutamyl-L-histidyl-L-proline amide Natural products NC(=O)C1CCCN1C(=O)C(NC(=O)C1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-UHFFFAOYSA-N 0.000 description 1
108010047294 Lamins Proteins 0.000 description 1
102000006835 Lamins Human genes 0.000 description 1
239000005639 Lauric acid Substances 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
108010047357 Luminescent Proteins Proteins 0.000 description 1
102000006830 Luminescent Proteins Human genes 0.000 description 1
102000003959 Lymphotoxin-beta Human genes 0.000 description 1
108090000362 Lymphotoxin-beta Proteins 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
102000001291 MAP Kinase Kinase Kinase Human genes 0.000 description 1
108010075654 MAP Kinase Kinase Kinase 1 Proteins 0.000 description 1
108060006687 MAP kinase kinase kinase Proteins 0.000 description 1
102000018721 Macroglobulins Human genes 0.000 description 1
108010091934 Macroglobulins Proteins 0.000 description 1
102000013460 Malate Dehydrogenase Human genes 0.000 description 1
108010026217 Malate Dehydrogenase Proteins 0.000 description 1
108010059724 Micrococcal Nuclease Proteins 0.000 description 1
102100023482 Mitogen-activated protein kinase 14 Human genes 0.000 description 1
102100033115 Mitogen-activated protein kinase kinase kinase 1 Human genes 0.000 description 1
101710154541 Modulator protein Proteins 0.000 description 1
YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 1
102000007474 Multiprotein Complexes Human genes 0.000 description 1
108010085220 Multiprotein Complexes Proteins 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
101000606416 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Acyltransferase PE Proteins 0.000 description 1
QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
108010079364 N-glycylalanine Proteins 0.000 description 1
108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
235000021314 Palmitic acid Nutrition 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
241000577979 Peromyscus spicilegus Species 0.000 description 1
102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
108010002519 Prolactin Receptors Proteins 0.000 description 1
102100029000 Prolactin receptor Human genes 0.000 description 1
101710176177 Protein A56 Proteins 0.000 description 1
108091034057 RNA (poly(A)) Proteins 0.000 description 1
239000013614 RNA sample Substances 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
208000025747 Rheumatic disease Diseases 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
108700012920 TNF Proteins 0.000 description 1
102000003715 TNF receptor-associated factor 4 Human genes 0.000 description 1
108090000008 TNF receptor-associated factor 4 Proteins 0.000 description 1
102000003718 TNF receptor-associated factor 5 Human genes 0.000 description 1
108090000001 TNF receptor-associated factor 5 Proteins 0.000 description 1
101150056647 TNFRSF4 gene Proteins 0.000 description 1
101710140983 TRAF family member-associated NF-kappa-B activator Proteins 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
239000000627 Thyrotropin-Releasing Hormone Substances 0.000 description 1
102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 1
101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 1
102000011409 Transcobalamins Human genes 0.000 description 1
108010023603 Transcobalamins Proteins 0.000 description 1
102000004338 Transferrin Human genes 0.000 description 1
108090000901 Transferrin Proteins 0.000 description 1
108050009189 Translin Proteins 0.000 description 1
206010052779 Transplant rejections Diseases 0.000 description 1
102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 1
108060008747 Ubiquitin-Conjugating Enzyme Proteins 0.000 description 1
102000003431 Ubiquitin-Conjugating Enzyme Human genes 0.000 description 1
102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 1
108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 1
108010046334 Urease Proteins 0.000 description 1
206010046865 Vaccinia virus infection Diseases 0.000 description 1
108010031770 Vesicular Transport Adaptor Proteins Proteins 0.000 description 1
102000005456 Vesicular Transport Adaptor Proteins Human genes 0.000 description 1
229930003270 Vitamin B Natural products 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
229940022698 acetylcholinesterase Drugs 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000009692 acute damage Effects 0.000 description 1
239000007801 affinity label Substances 0.000 description 1
108010047495 alanylglycine Proteins 0.000 description 1
125000003172 aldehyde group Chemical group 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
108010004469 allophycocyanin Proteins 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
230000004075 alteration Effects 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
229940025131 amylases Drugs 0.000 description 1
208000022531 anorexia Diseases 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
108010062796 arginyllysine Proteins 0.000 description 1
125000003435 aroyl group Chemical group 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
229960003272 asparaginase Drugs 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
108010038633 aspartylglutamate Proteins 0.000 description 1
230000003416 augmentation Effects 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
230000035578 autophosphorylation Effects 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
238000005415 bioluminescence Methods 0.000 description 1
230000029918 bioluminescence Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
238000006664 bond formation reaction Methods 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
125000002837 carbocyclic group Chemical group 0.000 description 1
150000001720 carbohydrates Chemical group 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
238000010822 cell death assay Methods 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000003593 chromogenic compound Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
239000013078 crystal Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
230000001461 cytolytic effect Effects 0.000 description 1
230000007711 cytoplasmic localization Effects 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007123 defense Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000011981 development test Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000010586 diagram Methods 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
230000002900 effect on cell Effects 0.000 description 1
230000000546 effect on cell death Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
230000001159 endocytotic effect Effects 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000009088 enzymatic function Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
230000000763 evoking effect Effects 0.000 description 1
239000011536 extraction buffer Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000001914 filtration Methods 0.000 description 1
ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000001215 fluorescent labelling Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
230000000799 fusogenic effect Effects 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
239000011521 glass Substances 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
125000003712 glycosamine group Chemical group 0.000 description 1
VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
239000000185 hemagglutinin Substances 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
230000000937 inactivator Effects 0.000 description 1
239000000411 inducer Substances 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000006525 intracellular process Effects 0.000 description 1
SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
238000011005 laboratory method Methods 0.000 description 1
210000005053 lamin Anatomy 0.000 description 1
210000001821 langerhans cell Anatomy 0.000 description 1
229910052747 lanthanoid Inorganic materials 0.000 description 1
150000002602 lanthanoids Chemical class 0.000 description 1
125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
150000004668 long chain fatty acids Chemical class 0.000 description 1
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
230000035800 maturation Effects 0.000 description 1
239000002609 medium Substances 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
238000001466 metabolic labeling Methods 0.000 description 1
TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
238000003032 molecular docking Methods 0.000 description 1
UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
235000007708 morin Nutrition 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
229940053128 nerve growth factor Drugs 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000004987 nonapoptotic effect Effects 0.000 description 1
230000002020 noncytotoxic effect Effects 0.000 description 1
230000012223 nuclear import Effects 0.000 description 1
230000005937 nuclear translocation Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
210000004248 oligodendroglia Anatomy 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000007119 pathological manifestation Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229960003330 pentetic acid Drugs 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 1
PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
230000004983 pleiotropic effect Effects 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
244000062804 prey Species 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
230000012846 protein folding Effects 0.000 description 1
230000006916 protein interaction Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
108700021653 rel Genes Proteins 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000003571 reporter gene assay Methods 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
150000003335 secondary amines Chemical class 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
241000894007 species Species 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
238000010257 thawing Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
229940034199 thyrotropin-releasing hormone Drugs 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
231100000827 tissue damage Toxicity 0.000 description 1
238000012546 transfer Methods 0.000 description 1
239000012581 transferrin Substances 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
238000003146 transient transfection Methods 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000005945 translocation Effects 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
MPSUGQWRVNRJEE-UHFFFAOYSA-N triazol-1-amine Chemical compound NN1C=CN=N1 MPSUGQWRVNRJEE-UHFFFAOYSA-N 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
230000005909 tumor killing Effects 0.000 description 1
238000003160 two-hybrid assay Methods 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
208000007089 vaccinia Diseases 0.000 description 1
235000019156 vitamin B Nutrition 0.000 description 1
239000011720 vitamin B Substances 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

ZA200201401A 1999-09-02 2002-02-19 Iren protein, its preparation and use. ZA200201401B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL13171999A IL131719A0 (en)	1999-09-02	1999-09-02	Iren protein its preparation and use

Publications (1)

Publication Number	Publication Date
ZA200201401B true ZA200201401B (en)	2003-05-28

Family

ID=11073213

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200201401A ZA200201401B (en)	1999-09-02	2002-02-19	Iren protein, its preparation and use.

Country Status (16)

Country	Link
US (2)	US7429648B1 (et)
EP (1)	EP1208197A1 (et)
JP (1)	JP2003508053A (et)
KR (1)	KR100820526B1 (et)
CN (1)	CN100482795C (et)
AR (1)	AR025482A1 (et)
AU (1)	AU784582B2 (et)
BR (1)	BR0014167A (et)
CA (1)	CA2383606A1 (et)
EA (1)	EA005775B1 (et)
EE (1)	EE200200096A (et)
IL (2)	IL131719A0 (et)
MX (1)	MXPA02002391A (et)
NO (1)	NO20020919L (et)
WO (1)	WO2001016314A1 (et)
ZA (1)	ZA200201401B (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4429726B2 (ja) *	2002-02-08	2010-03-10	ワイス	炎症性応答を調節するための組成物および方法
CA2493902A1 (en) *	2002-05-29	2003-12-04	Anges Mg, Inc.	Decoy composition for treating and preventing inflammatory disease
US8400998B2 (en)	2006-08-23	2013-03-19	Motorola Mobility Llc	Downlink control channel signaling in wireless communication systems
WO2014165769A1 (en) *	2013-04-05	2014-10-09	Mo Bio Laboratories, Inc.	Kits and methods for isolating protein from biological and environmental samples
CN105986001B (zh) *	2015-02-12	2019-12-03	上海交通大学	一种基于膜结合蛋白和荧光互补的高通量猎物拮抗剂筛选方法
CN105985979B (zh) *	2015-02-12	2020-03-24	上海交通大学	一种用于高通量受体基因筛查的新型膜蛋白酵母双杂交方法
WO2017040992A1 (en)	2015-09-04	2017-03-09	Mo Bio Laboratories, Inc.	Methods for co-isolation of nucelic acids and proteins
WO2019209597A1 (en)	2018-04-24	2019-10-31	Qiagen Sciences Llc	Nucleic acid isolation and inhibitor removal from complex samples

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100552547B1 (ko) *	1996-04-02	2006-05-12	에다 리서치 앤드 디벨럽먼트 컴퍼니 리미티드	Tnf수용체연합된인자(traf)조절물질,이의제조및이의용도
UA71889C2 (uk) *	1996-04-02	2005-01-17	Йєда Рісерч Енд Дівелопмент Ко. Лтд.	Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування

1999
- 1999-09-02 IL IL13171999A patent/IL131719A0/xx unknown
2000
- 2000-08-31 JP JP2001520861A patent/JP2003508053A/ja active Pending
- 2000-08-31 US US10/070,255 patent/US7429648B1/en not_active Expired - Fee Related
- 2000-08-31 EE EEP200200096A patent/EE200200096A/et unknown
- 2000-08-31 EP EP00954882A patent/EP1208197A1/en not_active Withdrawn
- 2000-08-31 AU AU67231/00A patent/AU784582B2/en not_active Ceased
- 2000-08-31 CA CA002383606A patent/CA2383606A1/en not_active Abandoned
- 2000-08-31 KR KR1020027002840A patent/KR100820526B1/ko not_active Expired - Fee Related
- 2000-08-31 CN CNB008150133A patent/CN100482795C/zh not_active Expired - Fee Related
- 2000-08-31 WO PCT/IL2000/000517 patent/WO2001016314A1/en not_active Ceased
- 2000-08-31 MX MXPA02002391A patent/MXPA02002391A/es unknown
- 2000-08-31 EA EA200200319A patent/EA005775B1/ru not_active IP Right Cessation
- 2000-08-31 BR BR0014167-4A patent/BR0014167A/pt not_active Application Discontinuation
- 2000-08-31 IL IL14844600A patent/IL148446A0/xx unknown
- 2000-09-01 AR ARP000104593A patent/AR025482A1/es unknown
2002
- 2002-02-19 ZA ZA200201401A patent/ZA200201401B/en unknown
- 2002-02-25 NO NO20020919A patent/NO20020919L/no not_active Application Discontinuation
2008
- 2008-09-09 US US12/207,269 patent/US20090075889A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1384878A (zh)	2002-12-11
CN100482795C (zh)	2009-04-29
JP2003508053A (ja)	2003-03-04
IL131719A0 (en)	2001-03-19
EA005775B1 (ru)	2005-06-30
BR0014167A (pt)	2002-05-07
US20090075889A1 (en)	2009-03-19
EE200200096A (et)	2003-04-15
HK1051876A1 (en)	2003-08-22
EA200200319A1 (ru)	2002-08-29
CA2383606A1 (en)	2001-03-08
US7429648B1 (en)	2008-09-30
KR20020059386A (ko)	2002-07-12
KR100820526B1 (ko)	2008-04-07
NO20020919D0 (no)	2002-02-25
AR025482A1 (es)	2002-11-27
IL148446A0 (en)	2002-09-12
NO20020919L (no)	2002-04-25
AU6723100A (en)	2001-03-26
AU784582B2 (en)	2006-05-04
MXPA02002391A (es)	2002-08-20
WO2001016314A1 (en)	2001-03-08
EP1208197A1 (en)	2002-05-29

Publication	Publication Date	Title
US8236507B2 (en)	2012-08-07	Modulators of TNF receptor associated factor (TRAF), their preparation and use
US20090075889A1 (en)	2009-03-19	Iren protein, its preparation and use
US7374909B1 (en)	2008-05-20	Modulators of intracellular inflammation, cell death and cell survival pathways
JP4351389B2 (ja)	2009-10-28	Ｔｎｆ／ｎｇｆレセプターファミリーおよびほかのタンパク質のレセプター機能調節物質
KR100552547B1 (ko)	2006-05-12	Tnf수용체연합된인자(traf)조절물질,이의제조및이의용도
AU767967B2 (en)	2003-11-27	Modulators of TNF receptor associated factor (TRAF), their preparation and use
IL126428A (en)	2010-02-17	Modulators of tnf receptor associated factor (traf), their preparation and use
JP2009148285A (ja)	2009-07-09	Ｔｎｆ／ｎｇｆレセプターファミリーおよびほかのタンパク質のレセプター機能調節物質
HK1051876B (en)	2009-08-28	Iren protein, its preparation and use
WO2002008270A2 (en)	2002-01-31	A mort-1 interacting protein, its preparation and use
IL133282A (en)	2007-12-03	Modulators of intracellular inflammation cell death and cell survival pathways